Moore JP - Search Results

1

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.

Arunachalam PS, Charles TP, Joag V, Bollimpelli VS, Scott MKD, Wimmers F, Burton SL, Labranche CC, Petitdemange C, Gangadhara S, Styles TM, Quarnstrom CF, Walter KA, Ketas TJ, Legere T, Jagadeesh Reddy PB, Kasturi SP, Tsai A, Yeung BZ, Gupta S, Tomai M, Vasilakos J, Shaw GM, Kang CY, Moore JP, Subramaniam S, Khatri P, Montefiori D, Kozlowski PA, Derdeyn CA, Hunter E, Masopust D, Amara RR, Pulendran B. Arunachalam PS, et al. Among authors: moore jp. Nat Med. 2020 Jun;26(6):932-940. doi: 10.1038/s41591-020-0858-8. Epub 2020 May 11. Nat Med. 2020. PMID: 32393800 Free PMC article.

2

Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.

Kang CY, Hariharan K, Nara PL, Sodroski J, Moore JP. Kang CY, et al. Among authors: moore jp. J Virol. 1994 Sep;68(9):5854-62. doi: 10.1128/JVI.68.9.5854-5862.1994. J Virol. 1994. PMID: 7520095 Free PMC article.

3

Neutralization assays using the BZ167 strain of human immunodeficiency virus type 1.

Moore JP, Montefiori DC. Moore JP, et al. J Infect Dis. 1997 Nov;176(5):1410-2. doi: 10.1086/514134. J Infect Dis. 1997. PMID: 9359750 No abstract available.

4

Why do we not have an HIV vaccine and how can we make one?

Burton DR, Moore JP. Burton DR, et al. Among authors: moore jp. Nat Med. 1998 May;4(5 Suppl):495-8. doi: 10.1038/nm0598supp-495. Nat Med. 1998. PMID: 9585194 No abstract available.

5

Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

Connor RI, Montefiori DC, Binley JM, Moore JP, Bonhoeffer S, Gettie A, Fenamore EA, Sheridan KE, Ho DD, Dailey PJ, Marx PA. Connor RI, et al. Among authors: moore jp. J Virol. 1998 Sep;72(9):7501-9. doi: 10.1128/JVI.72.9.7501-7509.1998. J Virol. 1998. PMID: 9696847 Free PMC article.

6

HIV vaccines. Magic of the occult?

Montefiori D, Moore JP. Montefiori D, et al. Among authors: moore jp. Science. 1999 Jan 15;283(5400):336-7. doi: 10.1126/science.283.5400.336. Science. 1999. PMID: 9925493 No abstract available.

7

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection.

Binley JM, Trkola A, Ketas T, Schiller D, Clas B, Little S, Richman D, Hurley A, Markowitz M, Moore JP. Binley JM, et al. Among authors: moore jp. J Infect Dis. 2000 Sep;182(3):945-9. doi: 10.1086/315774. Epub 2000 Aug 1. J Infect Dis. 2000. PMID: 10950795

8

HIV fusion and its inhibition.

LaBranche CC, Galasso G, Moore JP, Bolognesi DP, Hirsch MS, Hammer SM. LaBranche CC, et al. Among authors: moore jp. Antiviral Res. 2001 May;50(2):95-115. doi: 10.1016/s0166-3542(01)00130-9. Antiviral Res. 2001. PMID: 11369431 Review. No abstract available.

9

AIDS vaccine models: challenging challenge viruses.

Feinberg MB, Moore JP. Feinberg MB, et al. Among authors: moore jp. Nat Med. 2002 Mar;8(3):207-10. doi: 10.1038/nm0302-207. Nat Med. 2002. PMID: 11875482 No abstract available.

10

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

Veazey RS, Shattock RJ, Pope M, Kirijan JC, Jones J, Hu Q, Ketas T, Marx PA, Klasse PJ, Burton DR, Moore JP. Veazey RS, et al. Among authors: moore jp. Nat Med. 2003 Mar;9(3):343-6. doi: 10.1038/nm833. Epub 2003 Feb 10. Nat Med. 2003. PMID: 12579198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

752 results

Search Page